✦ LIBER ✦

Risk of inhibitor development in mild haemophilia A increases with age

✍ Scribed by E. P. MAUSER-BUNSCHOTEN; I. E. M DEN UIJL; R. E. G SCHUTGENS; G. ROOSENDAAL; K. FISCHER

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Age-dependent increase of FVIII:C in mil

✍ W. MIESBACH; S. ALESCI; S. KREKELER; E. SEIFRIED 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Characteristics of inhibitors in mild/mo

✍ K. PEERLINCK; M. JACQUEMIN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB

Environmental risk factors for inhibitor

✍ Elena Santagostino; Maria Elisa Mancuso; Angiola Rocino; Giacomo Mancuso; Maria 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Rituximab treatment of mild haemophilia

✍ S. DUNKLEY; G. KERSHAW; G. YOUNG; P. WARBURTON; R. LINDEMAN; S. MATTHEWS; F. REN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

Why do inhibitors develop? Principles of

✍ J. ASTERMARK 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

Tyr2105Cys mutation in exon 22 of FVIII

✍ M. FRANCHINI; D. GIRELLI; O. OLIVIERI; G. CASTAMAN; G. LIPPI; G. POLI; G. L. SAL 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB